Welcome To Medlock Healthcare
Medlock Healthcare is one of the best PCD Pharma Franchise Company in India which is working since 2015. It offers you PCD Pharma Franchise, third-party manufacturing, and Pharma distribution services in India. We manufacture a comprehensive assortment of pharma products that are accepted all over the world for their effective results and reliability.
Our WHO-GMP manufacturing units produce quality pharma products and it offers you more than 250+ DCGI-approved pharma products for different segments for better health.
These products include injections, tablets, syrups, dry syrups, capsules, powders, etc. It offers a wide range of pharma products under the allopathic range as well as provides an exclusive monopoly based pharma franchise in India.
Company Factsheet
| Basic Information | |
|---|---|
| Nature of Business | PCD Pharma Franchise & Pharmaceutical Manufacturer |
| Additional Business |
|
| Company CEO / Managing Director | Mr. Sachin Jindal |
| Registered Address | Plot No. 203, Industrial Area Phase 2, Panchkula – 134113, Haryana, India |
| Industry | Pharmaceutical Manufacturing, Trading & Distribution of Allopathic Medicines including Tablets, Capsules, Injections, Syrups, Suspensions, Dry Syrups, Ointments, Sachets, Powders and other Healthcare Formulations. |
| Total Number of Employees | Upto 10 People |
| Year of Establishment | 2015 |
| Legal Status of Firm | Partnership |
| Statutory Profile | |
| Banker | ICICI Bank |
| GST No. | 06ABEFM5459L1ZU |
| GST Registration Date | 12-01-2021 |
| Packaging, Payment & Shipment Details | |
| Payment Mode |
|
| Shipment Mode | By Road, Courier & Transport |
Analgesic
Anthelmintics
Capsules
Creams
Dental Range
Drops
Dry Syrups
Ear Drops
Eye drops
General Range
Gynecological Range
Liver tablets
Lotion
MouthWash
PCD Pharma Franchise
Suspension
Syrups
Tablets
Our Product Ranges
Business Info
- Plot No. 203, 2nd Floor, Industrial Area, Phase 2, Panchkula, Haryana 134113, India
- 07942556113
- medlockhealthcare@gmail.com
Statistics
-
Views322
-
Ratings0
Leave a Reply